Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Schering in-licenses human antibody for gastric cancer

Dec. 2, 1999

Biomira enters collaborative agreement, licenses two patents for cancer vaccine

Nov. 29, 1999

Preliminary survival data from single Maxamine site submitted to ASCO

Nov. 24, 1999

AAPS news: clinical pharmacokinetic analysis of B43-genistein in patients

Nov. 23, 1999

Novel prostate cancer therapy in development at Procyon detailed at international conference

Nov. 23, 1999

NY-ESO-1-derived peptides and their use in cancer therapy and diagnosis

Nov. 23, 1999

StressGen to codevelop HspE7 with NCI for HPV diseases

Nov. 17, 1999

First approval granted for Melacine melanoma therapeutic vaccine

Nov. 5, 1999

Maxamine in combination with IL-2 shows positive results in brain cancer model

Nov. 3, 1999

Celltech Chiroscience development partner files for FDA approval of AML treatment

Nov. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...